MedTrace Logo

Conduction System Pacing International Registry (CONSPIRE)

NCT04831125 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 383

Last updated 2026-03-03

No results posted yet for this study

Summary

The purpose of this registry study is to collect information about routine clinical practices with device implantation to treat bradycardia and cardiac systolic dysfunction (heart rhythm disorders) across global centers of excellence in cardiac pacing. In particular, this study will examine the use of conduction system pacing (CSP) in clinical practice. Information collected in the registry will help researchers better characterize strengths and limitations of current technology and treatments.

Conditions

Interventions

OTHER

Data collection

Data collection on the use of pacemaker, implantable cardioverter-defibrillator (ICD), and cardiac resynchronization therapy (CRT) devices and leads that are approved for clinical use.

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    collaborator INDUSTRY

  • University of Chicago

    lead OTHER

Principal Investigators

  • Gaurav A Upadhyay, MD · University of Chicago

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-04
Primary Completion
2026-02-05
Completion
2026-02-05

Countries

  • United States
  • Netherlands
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04831125 on ClinicalTrials.gov